NVO

Get Ready For the Next Dividend Rush

A dividend rush is on as companies begin to go ex-dividend. Here is a list to follow on companies with dividend payments coming up More 

4 Pharma Stocks to Sell

Sell these four bitter pills before they make your profits sicken. More 

5 Stocks You Should Have Sold Yesterday

These stocks have low volatility and there seems to be only downside left. Make sure you sell these stinkers now if you're unlucky enough to own them. More 

Winners After Novo Nordisk’s Insulin Rejection

Eli Lilly and Sanofi look like the biggest players that are best suited to benefit from Novo Nordisk's diabetes-drug setback, but a smaller player could emerge, too. More 

Little News, Little Wiggle — Monday’s IP Market Recap

A slow Monday featured a lack of economic or earnings news and led investors to mostly sit on the sidelines for the day. More 

12 Intraday Movers and Shakers

Federal regulators have sent a much-hyped Novo Nordisc (NVO) drug back to the drawing board...which is great for competitors like Sanofi (SNY) More 

3 Healthcare Stocks Ready for a Breather

It's the hottest sector in the S&P 500 so far this year, and that means some big-name pullbacks are likely. Here are three likely candidates. More